Literature DB >> 25573003

Synergy in activating class I PI3Ks.

John E Burke1, Roger L Williams2.   

Abstract

The class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that transduce a host of cellular signals and regulate a broad range of essential functions including growth, proliferation, and migration. As such, PI3Ks have pivotal roles in diseases such as cancer, diabetes, primary immune disorders, and inflammation. These enzymes are activated downstream of numerous activating stimuli including receptor tyrosine kinases, G protein-coupled receptors (GPCRs), and the Ras superfamily of small G proteins. A major challenge is to decipher how each PI3K isoform is able to successfully synergize these inputs into their intended signaling function. This article highlights recent progress in characterizing the molecular mechanisms of PI3K isoform-specific activation pathways, as well as novel roles for PI3Ks in human diseases, specifically cancer and immune diseases. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; lipid kinases; lipid signaling; phosphoinositide 3 kinases; phosphoinositides; primary immunodeficiencies

Mesh:

Substances:

Year:  2015        PMID: 25573003     DOI: 10.1016/j.tibs.2014.12.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  49 in total

1.  Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells.

Authors:  Chenchen He; Shaofeng Duan; Liang Dong; Yifen Wang; Qingting Hu; Chunjing Liu; Marcus L Forrest; Jeffrey M Holzbeierlein; Suxia Han; Benyi Li
Journal:  Prostate       Date:  2017-06-20       Impact factor: 4.104

Review 2.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

Review 3.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

Review 4.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

5.  Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1).

Authors:  Lucie Heurtier; Hicham Lamrini; Loïc Chentout; Marie-Céline Deau; Amine Bouafia; Jérémie Rosain; Jean-Marc Plaza; Mélanie Parisot; Benoit Dumont; Delphine Turpin; Etienne Merlin; Despina Moshous; Nathalie Aladjidi; Bénédicte Neven; Capucine Picard; Marina Cavazzana; Alain Fischer; Anne Durandy; Jean-Louis Stephan; Sven Kracker
Journal:  Haematologica       Date:  2017-04-20       Impact factor: 9.941

6.  And Akt-ion! IQGAP1 in control of signaling pathways.

Authors:  Suyong Choi; Richard A Anderson
Journal:  EMBO J       Date:  2017-03-20       Impact factor: 11.598

Review 7.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 8.  Dynamic structural biology at the protein membrane interface.

Authors:  John E Burke
Journal:  J Biol Chem       Date:  2019-01-28       Impact factor: 5.157

Review 9.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

10.  Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.

Authors:  Braden D Siempelkamp; Manoj K Rathinaswamy; Meredith L Jenkins; John E Burke
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.